Kate Broderick

Kate Broderick currently serves as Chief Innovation Officer at Maravai LifeSciences and as Senior Vice President at TriLink BioTechnologies, both positions held since October 2022 and June 2022, respectively. Prior to these roles, Kate Broderick worked at Inovio Pharmaceuticals Inc. from February 2007 to July 2022, progressing through several leadership roles, including Senior Vice President of Research & Development and Senior Director of Research & Development. Earlier career experience includes a position as Postdoctoral Research Scholar at the University of California, San Diego, where research focused on cyanide toxicity models and nitric oxide releasing compounds. Academic qualifications include a Doctor of Philosophy in Molecular Genetics and a Bachelor of Science in Genetics, both earned at the University of Glasgow.